Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates
This study is looking at ways to increase lung cancer screening rates, especially since breast cancer screening is more commonly used. Researchers want to see if using advocates and supporters, including people who already get cancer screenings or those who accompany friends/family to appointments, can help encourage more eligible people to get lung cancer screenings. You might be able to join if you are between 40 and 80 years old, regardless of gender, and have a history of smoking or a close family member with a smoking history. The study will measure if these efforts lead to more people getting screened for lung and breast cancer over three years. The goal is to understand and overcome reasons why lung cancer screening isn't used as much, like fear or lack of awareness.
- Study design
- This interventional study plans to enroll 800 participants. It is not specified if the study is randomized or blinded.
- What's involved
- You would access an electronic patient portal with educational materials at the start and at 1- and 2-year follow-ups. You would also interact with a patient navigator and receive materials to share with friends/family.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants are followed yearly for up to 3 years after the study intervention is completed.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ashley E Prosper · PRINCIPAL_INVESTIGATOR · UCLA / Jonsson Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Increased rates of lung and breast cancer screening adherenceUp to 3 years
By following up with patients over the defined study period and assessing whether they obtained an incidence screen completed at one-year +/- 3 months from the recommended time. Will also measure the rates of survey completion by consented participants, the number of clicks and time spent reviewing educational materials, and the number of new participants who contacted the program through a referral by another participant.